Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Mike Mensinger

Chief Product Officer at Beta Bionics, Inc. (BBNX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $539K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 17SEC BBNXBeta Bionics, Inc. Sell Plan 2,650177,390 held (−1%) $22.00 $58K -19.9%
Sep 3SEC BBNXBeta Bionics, Inc. Sell 4,375180,040 held (−2%) $19.11 $84K -7.7%
Jun 3SEC BBNXBeta Bionics, Inc. Sell 4,378184,415 held (−2%) $12.61 $55K +39.8%
Mar 3SEC BBNXBeta Bionics, Inc. Sell 1,064188,793 held (−1%) $12.36 $13K +42.6%
Jan 7SEC BBNXBeta Bionics, Inc. Sell Plan 2,20080,752 held (−3%) $30.10 $66K -41.4%
Jan 5SEC BBNXBeta Bionics, Inc. Sell Plan 7,20083,552 held (−8%) $29.56 $213K -40.4%
Jan 5SEC BBNXBeta Bionics, Inc. Sell Plan 60082,952 held (−1%) $30.20 $18K -41.6%
Dec 4SEC BBNXBeta Bionics, Inc. Sell 1,06390,752 held (−1%) $29.34 $31K -39.9%
  • Sell

    Chief Product Officer Mike Mensinger sold $58K of BBNX at $22.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Product Officer Mike Mensinger sold $66K of BBNX at $30.10 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Product Officer Mike Mensinger sold $213K of BBNX at $29.56 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Product Officer Mike Mensinger sold $18K of BBNX at $30.20 — pre-scheduled 10b5-1 plan sale.